Form D · Other Health Care
Cardiosense, Inc.
Chicago, IL · CIK 0001957335
Offering snapshot reported Aug 24, 2026 · SEC filing
- Reported sold
- $26.1M Offering amount: $42M
- Investors reported
- 30 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 7, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 24, 2026 | Initial | $26,137,050 | No comparison | 30 | SEC filing |
| Dec 9, 2022 | Initial | $9,084,327 | No comparison | 28 | SEC filing |
Offering details
- Securities
- Equity, Security to be acquired, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-595113
Convertible Promissory Notes have converted into equity in connection with this transaction
Source: Form D, filed Aug 24, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Andrew Michael Carek | Executive |
| Lauren Pierce Flickinger | Director |
| Daniel Gottlieb | Director |
| Amit K. Gupta | Director, Executive |
| Omer Tolga Inan | Director, Executive |
| Eric Meizlish | Director, Executive |
| Bimal Shah | Director |
| Jeff Terrell | Director |
| Jeffrey Trost | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
400 N. Aberdeen St. Suite 1050
Chicago, IL, 60642
Chicago, IL, 60642